Duke Cancer Institute (DCI) - Duke Cancer Center — Durham, North Carolina

Duke Cancer Institute (DCI) - Duke Cancer Center is a clinical research site located in Durham, North Carolina, United States 27710-2000.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Cancer Institute (DCI) - Duke Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer.

Sponsors: Biosplice Therapeutics, Inc., Tyra Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute (DCI) - Duke Cancer Center?

Duke Cancer Institute (DCI) - Duke Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute (DCI) - Duke Cancer Center conducted?

Duke Cancer Institute (DCI) - Duke Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer.

Is Duke Cancer Institute (DCI) - Duke Cancer Center accredited by Crixeo Health?

Duke Cancer Institute (DCI) - Duke Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute (DCI) - Duke Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.